Metropolitan Life Insurance Company (MetLife)’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-70,020
| Closed | -$7.96M | – | 22 |
|
|
2024
Q1 | $7.96M | Sell |
70,020
-616
| -0.9% | -$70.6K | 0.35% | 47 |
|
|
2023
Q4 | $7.77M | Sell |
70,636
-1,163
| -2% | -$116K | 0.37% | 45 |
|
|
2023
Q3 | $6.95M | Sell |
71,799
-3,983
| -5% | -$418K | 0.36% | 44 |
|
|
2023
Q2 | $8.26M | Sell |
75,782
-2,204
| -3% | -$235K | 0.4% | 43 |
|
|
2023
Q1 | $7.9M | Sell |
77,986
-20,732
| -21% | -$2.19M | 0.41% | 42 |
|
|
2022
Q4 | $10.8M | Sell |
98,718
-3,579
| -3% | -$371K | 0.48% | 37 |
|
|
2022
Q3 | $9.9M | Sell |
102,297
-1,211
| -1% | -$129K | 0.47% | 36 |
|
|
2022
Q2 | $11.2M | Sell |
103,508
-3,649
| -3% | -$414K | 0.49% | 34 |
|
|
2022
Q1 | $12.7M | Sell |
107,157
-132,928
| -55% | -$16.5M | 0.45% | 41 |
|
|
2021
Q4 | $33.8M | Sell |
240,085
-6,472
| -3% | -$828K | 0.46% | 30 |
|
|
2021
Q3 | $29.1M | Sell |
246,557
-8,674
| -3% | -$1.07M | 0.42% | 37 |
|
|
2021
Q2 | $29.6M | Buy |
255,231
+4,954
| +2% | +$578K | 0.42% | 35 |
|
|
2021
Q1 | $30M | Sell |
250,277
-13,546
| -5% | -$1.6M | 0.45% | 34 |
|
|
2020
Q4 | $28.9M | Sell |
263,823
-12,081
| -4% | -$1.31M | 0.43% | 39 |
|
|
2020
Q3 | $30M | Sell |
275,904
-11,608
| -4% | -$1.18M | 0.51% | 27 |
|
|
2020
Q2 | $26.3M | Sell |
287,512
-10,168
| -3% | -$919K | 0.47% | 36 |
|
|
2020
Q1 | $23.5M | Sell |
297,680
-2,672
| -0.9% | -$223K | 0.48% | 35 |
|
|
2019
Q4 | $26.1M | Buy |
300,352
+1,680
| +0.6% | +$141K | 0.42% | 40 |
|
|
2019
Q3 | $25M | Buy |
298,672
+38,446
| +15% | +$3.27M | 0.42% | 38 |
|
|
2019
Q2 | $21.9M | Buy |
260,226
+21,640
| +9% | +$1.7M | 0.37% | 47 |
|
|
2019
Q1 | $19.1M | Sell |
238,586
-10,652
| -4% | -$793K | 0.35% | 56 |
|
|
2018
Q4 | $18M | Sell |
249,238
-573
| -0.2% | -$40.3K | 0.36% | 50 |
|
|
2018
Q3 | $18.3M | Sell |
249,811
-9,375
| -4% | -$616K | 0.31% | 61 |
|
|
2018
Q2 | $15.8M | Sell |
259,186
-5,737
| -2% | -$348K | 0.26% | 71 |
|
|
2018
Q1 | $15.9M | Buy |
264,923
+1,609
| +0.6% | +$96.9K | 0.22% | 67 |
|
|
2017
Q4 | $15M | Sell |
263,314
-560,370
| -68% | -$31.1M | 0.2% | 75 |
|
|
2017
Q3 | $44M | Sell |
823,684
-16,600
| -2% | -$833K | 0.28% | 60 |
|
|
2017
Q2 | $40.8M | Sell |
840,284
-26,229
| -3% | -$1.19M | 0.28% | 60 |
|
|
2017
Q1 | $38.5M | Buy |
866,513
+122,244
| +16% | +$5.28M | 0.27% | 69 |
|
|
2016
Q4 | $28.6M | Sell |
744,269
-13,609
| -2% | -$540K | 0.21% | 91 |
|
|
2016
Q3 | $32.1M | Sell |
757,878
-5,001
| -0.7% | -$214K | 0.23% | 79 |
|
|
2016
Q2 | $30M | Sell |
762,879
-10,230
| -1% | -$407K | 0.22% | 81 |
|
|
2016
Q1 | $32.3M | Sell |
773,109
-23,561
| -3% | -$933K | 0.25% | 76 |
|
|
2015
Q4 | $35.8M | Sell |
796,670
-13,575
| -2% | -$599K | 0.27% | 70 |
|
|
2015
Q3 | $32.6M | Sell |
810,245
-13,952
| -2% | -$658K | 0.23% | 80 |
|
|
2015
Q2 | $40.5M | Sell |
824,197
-14,788
| -2% | -$710K | 0.28% | 66 |
|
|
2015
Q1 | $38.9M | Sell |
838,985
-9,336
| -1% | -$429K | 0.29% | 68 |
|
|
2014
Q4 | $38.2M | Sell |
848,321
-13,981
| -2% | -$609K | 0.26% | 73 |
|
|
2014
Q3 | $35.9M | Sell |
862,302
-11,473
| -1% | -$485K | 0.26% | 77 |
|
|
2014
Q2 | $35.7M | Sell |
873,775
-68,390
| -7% | -$2.69M | 0.25% | 81 |
|
|
2014
Q1 | $36.3M | Sell |
942,165
-16,269
| -2% | -$627K | 0.25% | 79 |
|
|
2013
Q4 | $36.7M | Sell |
958,434
-9,504
| -1% | -$350K | 0.26% | 79 |
|
|
2013
Q3 | $32.1M | Sell |
967,938
-7,975
| -0.8% | -$280K | 0.25% | 81 |
|
|
2013
Q2 | $34M | Buy |
+975,913
| New | +$35.8M | 0.27% | 67 |
|
Other funds holding ABT
Metropolitan Life Insurance Company (MetLife)'s ABT Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Abbott (ABT) in Q2 2024, closing a stake of 70,020 shares — an estimated $7.96M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ABT in Q2 2013 and held it in 44 quarters. The position peaked at $44M in Q3 2017. 2,864 funds tracked by Wall St. Rank hold ABT as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Abbott position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 70,020 Abbott shares in Q2 2024, an estimated $7.96M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Abbott in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Abbott position peaked at $44M in Q3 2017.
- 2,864 funds tracked by Wall St. Rank held Abbott as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.